Laurus Labs to buy 26% stake in cell therapy firm ImmunoACT for ₹46 cr.

Laurus Labs has signed an investment agreement with Immunoadoptive Cell Therapy Pvt. Ltd. (ImmunoACT) to acquire 26.62% stake in the advanced cell and

from The Hindu - Business